Stock Price
160.07
Daily Change
-4.45%
Yearly
22.17%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Acadia Pharmaceuticals 21.18 -0.31 -1.44% -59.91%
Acorda Therapeutics 1.86 -0.06 -3.13% -75.53%
Agios Pharmaceuticals 29.80 -0.56 -1.84% -37.22%
Alnylam Pharmaceuticals 136.41 -1.90 -1.37% -20.87%
Alexion Pharmaceuticals 182.50 0 0% 70.54%
Amgen 227.72 -1.18 -0.52% -10.17%
Arrowhead Research 50.84 -1.67 -3.18% -38.05%
Biogen 220.52 -5.39 -2.39% -18.16%
Bluebird Bio 7.24 0.31 4.47% -84.48%
BioMarin Pharmaceutical 84.65 0.20 0.24% -3.80%
Esperion Therapeutics 3.78 0.01 0.27% -85.42%
Gilead Sciences 68.51 0.70 1.03% 2.35%
GlaxoSmithKline 1,644.80 8.20 0.50% 19.17%
GW Pharmaceuticals 218.96 0 0% 108.53%
Intercept Pharmaceuticals 15.41 -1.59 -9.35% -47.69%
Incyte Corp 74.79 0.03 0.04% -23.60%
Ionis Pharmaceuticals 29.88 -0.13 -0.43% -51.23%
Mirati Therapeutics 114.03 -4.31 -3.64% -46.83%
Puma Biotechnology 2.40 -0.12 -4.76% -78.46%
Ultragenyx Pharmaceutical 67.17 -1.80 -2.61% -52.18%
Regeneron Pharmaceuticals 621.40 7.02 1.14% 15.55%
Seattle Genetics 127.55 -5.51 -4.14% -30.21%
Sangamo BioSciences 5.68 -0.25 -4.22% -62.01%
Sarepta Therapeutics 63.47 -1.12 -1.73% -35.39%
United Therapeutics 200.06 0.09 0.05% 19.29%
Vertex Pharmaceuticals 228.08 -0.53 -0.23% -4.00%

Indexes Price Day Year
USNDX 14438 -408.06 -2.75% 8.02%

Moderna Inc
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger RNA (mRNA). The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. The Company develops technologies that enable the development of mRNA medicines for diverse applications. The Company has created modalities, including Prophylactic vaccines, Systemic secreted and cell surface therapeutics, Cancer vaccines, Intratumoral immuno-oncology, Localized regenerative therapeutics, and Systemic intracellular therapeutics. Its diverse development pipeline which consists of 27 development candidates across its 24 programs.